American Journal of Biomedical Research
ISSN (Print): 2328-3947 ISSN (Online): 2328-3955 Website: http://www.sciepub.com/journal/ajbr Editor-in-chief: Hari K. Koul
Open Access
Journal Browser
Go
American Journal of Biomedical Research. 2018, 6(1), 11-19
DOI: 10.12691/ajbr-6-1-2
Open AccessArticle

Clinical Study on the Timing of Emergency Gastroscopy in Liver Cirrhotic Patients with Esophageal Variceal Bleeding

Li-xin Hou1, Bao-xia Han2, Shuang Li1, You-shang Hong1 and Xiao-jun Gou1, 3,

1Digestive department, Baoshan District Hospital of Integrated Traditional Chinese and Western Medicine of Shanghai, Shanghai 201999, China

2Blood room of Second Affiliated Hospital of Soochow University, Jiangsu Suzhou 215004, China

3College of Pharmacy, Shaanxi University of Chinese Medicine, Shaanxi Xianyang, 712083, China

Pub. Date: March 15, 2018

Cite this paper:
Li-xin Hou, Bao-xia Han, Shuang Li, You-shang Hong and Xiao-jun Gou. Clinical Study on the Timing of Emergency Gastroscopy in Liver Cirrhotic Patients with Esophageal Variceal Bleeding. American Journal of Biomedical Research. 2018; 6(1):11-19. doi: 10.12691/ajbr-6-1-2

Abstract

Esophageal variceal bleeding is a common complication of liver cirrhosis,and gastroscopic therapy has gradually become a significant clinical treatment for it. However, the timing of treatment with gastroscopy in liver cirrhotic patients with upper gastrointestinal bleeding is still controversial. In this study, 138 cases of liver cirrhotic patients with esophageal hemorrhage were retrospectively analyzed and followed up. Patients were divided into 4 groups based on whether they underwent gastroscopy and the first timing of gastroscopy, including group A with emergency gastroscopy within 12 hours, group B with emergency gastroscopy within 12-24 hours, group C with emergency gastroscopy within 24-48 hours and group D with conservative treatment. Gastroscopy at different time points and results of treatment were analyzed ,and the bleeding detection rate, success rate of hemostasis, early recurrent bleeding rate, mortality rate within a year and average hospital stay were followed up in order to further explore the best time-window and value of treatment in liver cirrhotic patients with esophageal variceal bleeding by emergency gastroscopy. The results of this study showed that the success rate of hemostasis, mortality rate within a year and average hospital stay of patients in group B were superior than that of group A, C and D. This study also demonstrates that emergency gastroscopy can effectively reduce the early recurrent bleeding rate, mortality rate within a year and average days in hospitalization in liver cirrhotic patients with esophageal variceal bleeding, but have no effect on the success rate of hemostasis. This study indicates that emergency gastroscopy is an efficient and effective method to diagnose and treat liver cirrhotic patients with esophageal variceal bleeding at present, and the best time-window of treatment with emergency gastroscopy should be within 12h-24h after admission.

Keywords:
liver cirrhosis portal hypertension esophageal variceal bleeding emergency gastroscopy

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]  D. Schuppan, and N.H. Afdhal, “Liver cirrhosis,” Lancet, vol.371, no. 9615, pp. 838-851, 2008.
 
[2]  Y.Lu,J.Liu, C.Lin,H.Wang, Y.Jiang, J.Wang, P. Yang, and F. He, “Peroxiredoxin 2: a potential biomarker for early diagnosis of hepatitis b virus related liver fibrosis identified by proteomic analysis of the plasma,”Bmc Gastroenterology, vol. 10, no. 1, pp. 115, 2010.
 
[3]  Y. Yan, J.Y. Yang, Y.H. Mou, L.H. Wang, H Zhang, and C.F. Hu, “ Possible metabolic pathways of ethanol responsible for oxidative DNA damage in human peripheral lymphocytes,” Alcoholism-Clinical and Experimental Research, vol. 35, no. 1, pp. 1-9, 2011.
 
[4]  C. Fabris, P. Toniutto, E. Falleti, E. Fontanini, A. Cussigh, D. Bitetto, E. Fornasiere, E. Fumolo, C. Avellini, R. Minisini, and M. Pirisi, “MTHFR C677T polymorphism and risk of HCC in patients with liver cirrhosis: role of male gender and alcohol consumption,” Alcoholism-Clinical and Experimental Research, vol. 33, no. 1, pp. 102-107, 2009.
 
[5]  J. Chen, and J.D. Jia, “Progress in diagnosis and treatment of liver cirrhosis,” Chinese Journal of Hepatology, vol. 17, no. 4, pp. 241-243, 2009.
 
[6]  R. Jürgen, A.V. Samokhvalov, and K.D. Shield, “Global burden of alcoholic liver diseases,”Journal of Hepatology, vol. 59, no. 1, pp.160, 2013.
 
[7]  K.D. Kochanek, J.Q. Xu, S.L. Murphy, and A.M. Minio, “National Vital statistics Report Deaths:Preliminary Data for 2009,”Centers for Disease Control and Prevention, vol.59, pp. 1-51, 2011.
 
[8]  Korea National Statics Office. Annual Report on the Cause of Death Statics [M]. Korea National Statical Office. 2010.
 
[9]  S. Augustin, A. Gonzalez, and J. Genesca, “Acute esophageal variceal bleeding:Current strategies and new perspectives,”World Journal of Hepatology, vol. 2, no 7, pp. 261-274, 2010.
 
[10]  C.H. Zhu, and J.X. Hao, “Endoscopic variceal ligation versus β-blockers plus isosorbide mononitrate in prevention of esophageal variceal re-bleeding: a Meta-analysis,” Chinese Journal of Digestive Endoscopy, vol. 26, no. 3, pp. 128-133, 2009.
 
[11]  G.H. Lo, “he role of endoscopy in secondary prophylaxis of esophageal varices,” Clinics in Liver Disease, vol. 14, no. 2, pp. 307-323, 2010.
 
[12]  F. Schepis, C. Camma, D. Niceforo, A. Magnano, S. Pallio, M. Cinquegrani, G. D'amico, L. Pasta, A. Craxì, A. Saitta, and G. Raimondo, “Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection,” Hepatology, vol.33, no.2, pp.333-338, 2001.
 
[13]  L. Boyanova, and I. M itov, “Geographic map and evolution ofprimary Helicobacter pyloriresistance to antibacterialagents,” Expert Review of Anti-infective Therapy, vol.8, no.1, pp.59-70, 2014.
 
[14]  D. Tripathi, J.W. Fergnson, G. Therapondos, J.N. Plevris, and P.C. Hayes, “Recent advances in the management of bleeding gastric varices,” Alimentary Pharmacology & Therapeutics, vol. 24, no. 1, pp. 1-17, 2006.
 
[15]  A.K. Burroughs, “Octreotide in variceal bleeding,” Gut, vol. 35, no. Suppl3, pp. S23-27, 1994.
 
[16]  K. Stokkeland, L. Brandt, A. Ekbom, and R. Hultcrantz, “Improved prognosis for patients hospitalized with esophageal varices in Sweden 1969-2002” Hepatology, vol.43, no.3, pp.500-505, 2006.
 
[17]  G.V. Stiegmann, “Evolution of endoscopic therapy for esophageal varices,” Surgical Endoscopy & Other Interventional Techniques, vol. 20, no. S2, pp. S467-470.
 
[18]  H. Deng, X.S. Qi, and X.Z. Guo, “UK guidelines on the management of variceal haemorrhage in cirrhotic patients (2015): an excerpt of recommendations,” Journal of Clinical Hepatology, vol. 31, no. 6, pp. 852-854, 2015.
 
[19]  P. Svoboda, M. Konecny, A. Martinek, V. Hrabovsky , V. Prochazka V, and J. Ehrmann, “Acute upper gastrointestinal bleeding in liver cirrhosis patients” Biomedical Papers of the Medical Faculty of the University Palacký Olomouc Czechoslovakia, vol. 156, no. 3, p. 266-270, 2012.
 
[20]  L. Miu, “The Diagnostic and Therapeutic Values of Emergency Endoscopyin Liver Cirrhotic Patients with Upper Gastrointestinal Bleeding” Journal of Hunan Normal University (Medical Sciences), vol. 14, n. 6, pp. 115-120, 2017.
 
[21]  Portal hypertension group of Chinese Department of surgery, “Common understanding of diagnosis and treatment of esophageal and gastric variceal bleeding caused by cirrhosis of the portal hypertension (2015 Edition),” Chinese Journal of General Surgery, vol. 31, no. 2, pp. 167-170, 2016.
 
[22]  Chinese Society of Hepatology,Chinese Medical Association, “Guidelines for the diagnosis and treatment of esophageal and gastric variceal bleeding in cirrhotic portal hypertension,”Chinese Journal of Internal Medicine, vol. 55, no. 1, pp. 57-72, 2016.
 
[23]  Z.Y. Lu,L.S.Zhong, “Internal Medicine [M],the seventh edition,” Beijing: People's Health Publishing House, pp. 448, 452, 453, 484. 485, 2008.
 
[24]  Esophagogastric varicosity group of the Chinese Medical Association for digestive endoscopy, “Tentative guidelines for endoscopic diagnosis and treatment of varicosity and variceal bleeding in digestive tract (2009),” China Continuing Medical Education, vol. 2, no. 6, pp. 21-26, 2010.
 
[25]  U.Thalheimer, C. Triamos, J. Goulis, and A.K. Burroughs, “Management of varices in cirrhosis,” Expert Opin Pharmacother, vol. 12, no. 5, pp. 721-735, 2011.
 
[26]  J.R. Tafarel, L.H. Tolentino, L.M. Correa, D.R. Bonilha, P. Piauilino, FP. Martins, R.A. Rodrigues, F.S.Nakao, E.D. Libera, A.P. Ferrari, M.R. da Silveira Röhr, “Prediction of esophageal varices in hepatic cirrhosis by noninvasive markers,” European Journal of Gastroenterology & Hepatology, vol. 23, no. 9, pp. 754-758, 2011.
 
[27]  Z.H. Dong, Q.P. Meng, and L.F. Cheng, “Preventive and Therapeutic Progress of Rebleeding of Esophageal Varices,” Medical Recapitulate, vol. 13, no. 12, pp. 924-926, 2007.
 
[28]  S.K. Sarin, M. Wadhawan, S.R. Agarwal, P. Tyagi, and B.C. Sharma, “Endoscopic variceal ligation plus propranolol versus endoscopic variceal ligation alone in primary prophylaxis of variceal bleeding,” American Journal of Gastroenterology, vol. 100, no. 4, pp. 797-804, 2005.
 
[29]  D. Jaklewicz, W. Rózański, S. Wojtuń, and J. Gil, “Endoscopic methods of treatment of variceal haemorrhage,” Polski merkuriusz lekarski: organ Polskiego Towarzystwa Lekarskiego, vol. 22, no. 131, pp. 419-422, 2007.
 
[30]  Q.Y. Wang, T.S. Liu, W. Jiang, L. Dong, X.Z Sheng, S.C. Zhang, J.S. Gou, and W.B. Liu, “The prevention and treatment of hepatocirrhosis and its conplication,” National Medical Journal of China, vol.82, no. 17, pp. 1212-1216, 2002.
 
[31]  J. Cheung, I. Soo, R. Bastiampillai, Q. Zhu, and M. Ma, “Non-urgent endoscopy in stable acute variceal bleeding,” American Journal of Gastroenterology, vol. 104, no. 5, pp. 1125-1129, 2009.
 
[32]  Y.C. Hsu, C.S .Chung,C.H. Tseng, T.L . Lin, J.M. Liou, M.S. Wu, F.C. Hu, and H.P. Wang, “Delarisk factor for in-hospital mortality in acute variceal hemorrhage,” Journal of Gastroenterology & Hepatology, vol. 24, no.7, pp. 1294-1299, 2009.
 
[33]  Z.J. Chen, and M.L. Freeman, “Management of upper gastrointestinal bleeding emergencies: evidence-based medicine and practical considerations,” World Journal of Emergency Medicine, vol. 2, no. 1, pp. 5-12, 2011.
 
[34]  P.H. Chen, W.C. Chen, M.C. Hou, T.T. Liu, C.J. Chang, W.C. Liao, C.W. Su, H.M. Wang, H.C. Lin, F.Y. Lee, and S.D. Lee, “Delayed endoscopy increases rebleeding and mortality in patients with hematemesis and active esophageal variceal bleeding: a cohort study,” Journal of Hepatology, vol. 57, no. 6, pp. 1207-1213, 2012.
 
[35]  J. Cheung, I. Soo, R. Bastiampillai, Q. Zhu, and M. Ma, “Urgent VS non-urgent endoscopy in stable acute variceal bleeding,” American Journal of Gastroenterology, vol. 104, no. 5, pp. 1125-1129, 2009.
 
[36]  Y.C. Hsu, C.S .Chung, C.H. Tseng, T.L . Lin, J.M. Liou, M.S. Wu, F.C. Hu, and H.P. Wang, “Delarisk factor for in-hospital mortality in acute variceal hemorrhage,” Journal of Gastroenterology & Hepatology, vol. 24, no. 7, pp. 1294-1299, 2009.